Advertisement

Topics

Latest "Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis" News Stories

04:23 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis" found in our extensive news archives from over 250 global news sources.

More Information about Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis for you to read. Along with our medical data and news we also list Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis Clinical Trials, which are updated daily. BioPortfolio also has a large database of Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis Companies for you to search.

Showing "Adamis Pharmaceuticals Corp ADMP Financial Strategic SWOT Analysis" News Articles 1–25 of 29,000+

Wednesday 12th December 2018

Recordati SpA REC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryRecordati SpA Recordati, a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculoskeletal disorders and analgesia and urology diseases. It also offers cosmetics, dietary supplements, pregnancy test products, ...


Episurf Medical AB EPIS B Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryEpisurf Medical AB Episurf Medical, formerly Diamorph Medtech AB is a medical technology company that provides patientspecific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer Trochlea Solo, Episealer Trochlea Twin, Epiguide and toolkit; and MRI protocol. Episurf Medical...

TissueGen Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryTissueGen Inc TissueGen is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company's products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. TissueGen's products are used in sciatic nerve repair, peripheral nerve regeneration, spinal cord repair, ...


Dynatronics Corp DYNT Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryDynatronics Corp Dynatronics is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and rehab equipment, among others. It also offers exercise products, cardio equipment, pilates and yoga equi...

Humanwell Healthcare Group Co Ltd 600079 Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryHumanwell Healthcare Group Co Ltd Humanwell, formerly Wuhan Humanwell HiTech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anesthetics, biological products, herbal medicines, CNS medicines, women's health, antiinfection drugs, medical...

Santhera Announces Financial Results for the First Nine Months of 2018

Santhera Pharmaceuticals Holding AG / Santhera Announces Financial Results for the First Nine Months of 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and...

Santhera Launches Placement of Shares through Accelerated Bookbuilding

Santhera Pharmaceuticals Holding AG / Santhera Launches Placement of Shares through Accelerated Bookbuilding . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5...

Libertex Trading Platform Adds 5 CFDs on Cannabis Stocks

Libertex has added five new contracts for difference (CFDs) to its trading platform. Starting from December 11th, 2018, traders using our cross-channel platform will be able to trade with the five hottest instruments, which represent the world’s most popular companies operating in the growing sphere of marijuana production and processing. ...

EU5 Anesthesia Machines Market Outlook to 2025 [Report Updated: 12102018] Prices from USD $5096

EU5 Anesthesia Machines Market Outlook to 2025SummaryGlobalData's new report, EU5 Anesthesia Machines Market Outlook to 2025, provides key market data on the EU5 Anesthesia Machines market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Anesthesia Work Stations and Portable Anesthesia Delivery Machines.The report also provides c...

Patrick Treanor appointed President of Relypsa and member of the Executive Committee of Vifor Pharma Group

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005987/en/ Vifor Pharma Group is pleased to announce the appointment of Patrick Treanor as President of Relypsa on a permanent basis. He is also appointed to the Executive Committee of Vifor Pharma Group with immediate e...

PT. SOHO Industri Pharmasi Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryPT. SOHO Industri Pharmasi PT SOHO, a subsidiary of SOHO Global Health, is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company's products include analgesic, antiinflammatory, antipyretic, antibiotics, antifungal, antihistamine and antiallergy, antihyperlipidaemic, antipsychotic, antiviral, corticosteroid, h2 blocker, proton pump i...

Manipal Hospital Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryManipal Hospital, formerly Manipal Health Systems is a healthcare service provider that offers primary, secondary and tertiary healthcare services. The hospital offers services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, dental care, home healthcare, and others. It provides services in the areas of cardiovascular, neurology...

Tuesday 11th December 2018

Cellmid Ltd CDY Product Pipeline Analysis, 2018 Update [Report Updated: 10102018] Prices from USD $750

SummaryCellmid Ltd Cellmid, formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as midkine ELISA kit, advangen international hair loss products and evolis products. Cellmid develops CA...

Avacta Group Plc AVCT Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryAvacta Group Plc Avacta is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta's sensipod is an inclinical blood testing system that delivers ELISA tests. The company offers intellectual property rel...

[Personal View] Epidemic preparedness: why is there a need to accelerate the development of diagnostics?

Global epidemics of infectious diseases are increasing in frequency and severity. Diagnostics are needed for rapid identification of the cause of the epidemic to facilitate effective control and prevention. Lessons learned from the recent Ebola virus and Zika virus epidemics are that delay in developing the right diagnostic for the right population at the right time has been a costly barrier to di...

BELLUS Health Inc BLU Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryBELLUS Health Inc BELLUS Health is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company's pipeline products include BLU5937 for chronic cough, Shigamab for STEC related hemolytic syndrome sHUS; KIACTA for the treatment of a second indication called sarcoidosis; AMO01 related to Fragile X syndrome and ALZ801 for the treatment of Alzheimer'...

Solid Biosciences Inc SLDB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySolid Biosciences Inc Solid Biosciences is a life science company focused on developing therapies for duchenne muscular dystrophy DMD. Its pipeline product candidates include SGT001, a microdystrophin gene therapy administered through adenoassociated virus AAV stabilizes dystrophin glycoprotein complex and rescue muscle function; SB001, a monoclonal antibody to reduce fibrosis and inflammat...

Anchiano Therapeutics Ltd BICL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAnchiano Therapeutics Ltd Anchiano formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancerrelated diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's product pipeline candidates is being evaluated for the treatment of bladder cancer, ovarian cancer and pancrea...

Australia Dental Lasers Market Outlook to 2025 [Report Updated: 01092018] Prices from USD $4246

Australia Dental Lasers Market Outlook to 2025SummaryGlobalData's new report, Australia Dental Lasers Market Outlook to 2025, provides key market data on the Australia Dental Lasers market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Dental Surgical Lasers and Dental Welding Lasers.The report also provides company shares and ...

Author Correction: Comparing the Success Rate of Dacryocystorhinostomy With and Without Silicone Intubation: A Trial Sequential Analysis of Randomized Control Trials

Mexico CAD/CAM Systems and Materials Market Outlook to 2025 [Report Updated: 01092018] Prices from USD $4246

Mexico CAD/CAM Systems and Materials Market Outlook to 2025SummaryGlobalData's new report, Mexico CAD/CAM Systems and Materials Market Outlook to 2025, provides key market data on the Mexico CAD/CAM Systems and Materials market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments CAD/CAM Materials Market and CAD/CAM Systems Market.Th...

South Korea Hydrocephalus Shunts Market Outlook to 2025 [Report Updated: 01112018] Prices from USD $4246

South Korea Hydrocephalus Shunts Market Outlook to 2025SummaryGlobalData's new report, South Korea Hydrocephalus Shunts Market Outlook to 2025, provides key market data on the South Korea Hydrocephalus Shunts market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Hydrocephalus Valves and Hydrocephalus Catheters.The report also p...

Rite Aid to Release Third Quarter Results on December 19

Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2019 Third Quarter, which ended Dec. 1, 2018, on Wednesday, Dec. 19, 2018. The company will hold an analyst call at 5:00 p.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://www.riteaid.com/corporate/inv...

Arrowhead Pharmaceuticals, Inc. (ARWR) CEO Christopher Anzalone on Q4 2018 Results - Earnings Call Transcript

Streck Inc Product Pipeline Analysis, 2018 Update [Report Updated: 06122018] Prices from USD $750

SummaryStreck Inc Streck is a developer and manufacturer of hematology, immunology and molecular biology products for clinical and research laboratories. The company provide products such as offers body fluid, sedimentationrate, chemistry, whole blood, whole blood glucose and hemoglobin, instruments and consumables, antibiotic resistance kits, reagents and thermometers. It also provides laboratory...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks